References

References

  1. Amatu, A., et al. (2019). "Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer." Ann Oncol 30(Suppl_8): viii5-viii15.
  2. Barton, W. A., et al. (2006). "Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex." Nat Struct Mol Biol 13(6): 524-532.
  3. Bouyain, S., et al. (2005). "The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand." Proc Natl Acad Sci U S A 102(42): 15024-15029.
  4. Carafoli, F., et al. (2009). "Crystallographic insight into collagen recognition by Discoidin domain receptor 2." Structure 17(12): 1573-1581.
  5. Carafoli, F., et al. (2012). "Structure of the Discoidin domain receptor 1 extracellular region bound to an inhibitory Fab fragment reveals features important for signaling." Structure 20(4): 688-697.
  6. Chen, L., et al. (2023). "Structural basis for FGF hormone signaling." Nature 618(7966): 862-870.
  7. Chen, X., et al. (2008). "Structure of macrophage colony stimulating factor bound to FMS: diverse signaling assemblies of class III receptor tyrosine kinases." Proc Natl Acad Sci U S A 105(47): 18267-18272.
  8. Cho, H. S., et al. (2003). "Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab." Nature 421(6924): 756-760.
  9. De Munck, S., et al. (2021). "Structural basis of cytokine-mediated activation of ALK family receptors." Nature 600(7887): 143-147.
  10. Egea, J. and R. Klein (2007). "Bidirectional Eph-ephrin signaling during axon guidance." Trends Cell Biol 17(5): 230-238.
  11. Himanen, J. P., et al. (2010). "Architecture of Eph receptor clusters." Proc Natl Acad Sci U S A 107(24): 10860-10865.
  12. Jin, Z., et al. (2024). "PTK7: an underestimated contributor to human cancer." Front Oncol 14: 1448695.
  13. Kschonsak, M., et al. (2021). "Structures of HCMV Trimer reveal the basis for receptor recognition and cell entry." Cell 184(5): 1232-1244 e1216.
  14. Lemmon, M. A. and J. Schlessinger (2010). "Cell signaling by receptor tyrosine kinases." Cell 141(7): 1117-1134.
  15. Leppanen, V. M., et al. (2010). "Structural determinants of growth factor binding and specificity by VEGF receptor 2." Proc Natl Acad Sci U S A 107(6): 2425-2430.
  16. Leppanen, V. M., et al. (2017). "Structural basis of Tie2 activation and Tie2/Tie1 heterodimerization." Proc Natl Acad Sci U S A 114(17): 4376-4381.
  17. Leppanen, V. M., et al. (2013). "Structural and mechanistic insights into VEGF receptor 3 ligand binding and activation." Proc Natl Acad Sci U S A 110(32): 12960-12965.
  18. Li, J., et al. (2019). "Cryo-EM analyses reveal the common mechanism and diversification in the activation of RET by different ligands." Elife 8.
  19. Linger, R. M., et al. (2010). "Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors." Expert Opin Ther Targets 14(10): 1073-1090.
  20. Markovic-Mueller, S., et al. (2017). "Structure of the Full-length VEGFR-1 Extracellular Domain in Complex with VEGF-A." Structure 25(2): 341-352.
  21. Mason, E. O., et al. (2021). "Structure of the EphB6 receptor ectodomain." PLoS One 16(3): e0247335.
  22. Mirschberger, C., et al. (2013). "RG7116, a therapeutic antibody that binds the inactive HER3 receptor and is optimized for immune effector activation." Cancer Res 73(16): 5183-5194.
  23. Ogiso, H., et al. (2002). "Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains." Cell 110(6): 775-787.
  24. Plotnikov, A. N., et al. (1999). "Structural basis for FGF receptor dimerization and activation." Cell 98(5): 641-650.
  25. Qing, J., et al. (2009). "Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice." J Clin Invest 119(5): 1216-1229.
  26. Roszmusz, E., et al. (2001). "Localization of disulfide bonds in the frizzled module of Ror1 receptor tyrosine kinase." J Biol Chem 276(21): 18485-18490.
  27. Roy, J. P., et al. (2018). "The biochemistry, signaling and disease relevance of RYK and other WNT-binding receptor tyrosine kinases." Growth Factors 36(1-2): 15-40.
  28. Sasaki, T., et al. (2006). "Structural basis for Gas6-Axl signaling." EMBO J 25(1): 80-87.
  29. Shim, A. H., et al. (2010). "Structures of a platelet-derived growth factor/propeptide complex and a platelet-derived growth factor/receptor complex." Proc Natl Acad Sci U S A 107(25): 11307-11312.
  30. Stiegler, A. L., et al. (2006). "Crystal structure of the agrin-responsive immunoglobulin-like domains 1 and 2 of the receptor tyrosine kinase MuSK." J Mol Biol 364(3): 424-433.
  31. Stiegler, A. L., et al. (2009). "Crystal structure of the frizzled-like cysteine-rich domain of the receptor tyrosine kinase MuSK." J Mol Biol 393(1): 1-9.
  32. Uchikawa, E., et al. (2021). "Structural basis of the activation of c-MET receptor." Nat Commun 12(1): 4074.
  33. Uchikawa, E., et al. (2019). "Activation mechanism of the insulin receptor revealed by cryo-EM structure of the fully liganded receptor-ligand complex." Elife 8.
  34. Verstraete, K., et al. (2011). "Structural insights into the extracellular assembly of the hematopoietic Flt3 signaling complex." Blood 118(1): 60-68.
  35. Wang, L., et al. (2023). "Structural basis of the alkaline pH-dependent activation of insulin receptor-related receptor." Nat Struct Mol Biol 30(5): 661-669.
  36. Wehrman, T., et al. (2007). "Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors." Neuron 53(1): 25-38.
  37. Xu, K., et al. (2013). "Insights into Eph receptor tyrosine kinase activation from crystal structures of the EphA4 ectodomain and its complex with ephrin-A5." Proc Natl Acad Sci U S A 110(36): 14634-14639.
  38. Xu, Y., et al. (2021). "The Ephb2 Receptor Uses Homotypic, Head-to-Tail Interactions within Its Ectodomain as an Autoinhibitory Control Mechanism." Int J Mol Sci 22(19).
  39. Yang, Y., et al. (2010). "Direct contacts between extracellular membrane-proximal domains are required for VEGF receptor activation and cell signaling." Proc Natl Acad Sci U S A 107(5): 1906-1911.
  40. Yu, X., et al. (2013). "Structural basis for angiopoietin-1-mediated signaling initiation." Proc Natl Acad Sci U S A 110(18): 7205-7210.
  41. Yuzawa, S., et al. (2007). "Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor." Cell 130(2): 323-334.
  42. Zhang, X., et al. (2020). "Visualization of Ligand-Bound Ectodomain Assembly in the Full-Length Human IGF-1 Receptor by Cryo-EM Single-Particle Analysis." Structure 28(5): 555-561 e554.